Mr 1
reacted to and commented on
$Alphabet-A (GOOGL.US)$ I hope I can dump this stock at breakeven and move on.
2
1
Mr 1
voted
Dear mooers, have you joined Black Friday yet? To celebrate this exciting season, we’ve compiled moomoo’s exclusive deals to help you save big while investing smarter!
🟡 Offer 1: [New customer special] Free Stocks + 8.1% APY
🌟 Get up to 15 FREE stocks when you make your first deposit.
💰 Enjoy an 8.1% APY on uninvested cash for up to 3 months.
🟠 Offer 2: Refer & Earn $100 Cash Rewards
Already deposited? Refer a friend! For each friend who dep...
🟡 Offer 1: [New customer special] Free Stocks + 8.1% APY
🌟 Get up to 15 FREE stocks when you make your first deposit.
💰 Enjoy an 8.1% APY on uninvested cash for up to 3 months.
🟠 Offer 2: Refer & Earn $100 Cash Rewards
Already deposited? Refer a friend! For each friend who dep...
155
223
5
Mr 1
reacted to
$Alphabet-A (GOOGL.US)$ such a useess oiece of shit
4
Mr 1
voted
Hi, mooers!
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Palantir's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Palantir and earn plenty of rewards! Don't miss the chance to win big>>
$Palantir (PLTR.US)$ is releasing its Q2 earnings on August 5 after the bell. Unlock insights with Palantir Earnings Hub>>
For the details o...
Just a heads-up:
Earnings Challenge is in full swing! What's your take on Palantir's earnings and its stock performance? Now join the challenge, leverage moomoo's handy features to support your views on Palantir and earn plenty of rewards! Don't miss the chance to win big>>
$Palantir (PLTR.US)$ is releasing its Q2 earnings on August 5 after the bell. Unlock insights with Palantir Earnings Hub>>
For the details o...
80
120
11
Mr 1
liked and commented on
Mr 1
commented on
Mr 1
liked
$Novavax (NVAX.US)$ soared more than 20% Monday on a report that the U.S. Food and Drug Administration is considering recommending a new COVID-19 vaccine for the disease's JN.1 variant – a product that NVAX reportedly specializes in.
Novavax rose 21.2% to close at an 18-month high of $18.22 after Yahoo Finance reported that the FDA might soon recommend a JN.1 variant vaccine. The rally took NVAX to its highe...
Novavax rose 21.2% to close at an 18-month high of $18.22 after Yahoo Finance reported that the FDA might soon recommend a JN.1 variant vaccine. The rally took NVAX to its highe...
6
4
Mr 1 : same here, in tired of it. I should've sold it when it's came back up some weeks ago.